Associations between combinations of body mass index plus non-alcoholic fatty liver disease and diabetes mellitus among Korean adults.

Kim, Sang-Hwan; Lee, Ji-Won; Hwang, Hee-Jin
Asia Pacific journal of clinical nutrition
2011NA ; 20 ( 1 ) :14-20.
ÀúÀÚ »ó¼¼Á¤º¸
Kim, Sang-Hwan -
Lee, Ji-Won -
Hwang, Hee-Jin -
ABSTRACT
The purpose of this study was to investigate associations between combinations of body mass index (BMI) categories plus non-alcoholic fatty liver disease (NAFLD) and diabetes mellitus (DM) among Korean adults. We prepared the data of 5665 subjects aged 20 years and over who had visited a health promotion center. We excluded 582 subjects as they had a viral or alcoholic liver disease. According to BMI-NAFLD status, the subjects were categorized as non-obese (BMI<25 kg/m2) without NAFLD (n=2568), obese (BMI??5 kg/m2) without NAFLD (n=572), non-obese with NAFLD (n=748), or obese with NAFLD (n=1195). The prevalence of NAFLD was highest in the obese subjects with DM (87.9%). In non-obese and non-DM subjects, the prevalence of NAFLD was lowest (18.4%). After adjustment of age, gender, waist circumference, smoking status, alcohol drinking, regular exercise, the odd ratios for DM or DM plus impaired fasting glucose (IFG) of subjects with mild NAFLD regardless of obesity were almost 2-fold compared to non-obese subjects without NAFLD. Moreover, those of subjects with moderate or severe NAFLD regardless of obesity were about 4- fold. Clinicians and investigators need to pay attention to non-obese patients with fatty liver.
Fatty liver, glucose metabolism, diabetes, body mass index, obesity
MESH
Adult, Blood Glucose/analysis, *Body Mass Index, *Diabetes Complications, Diabetes Mellitus/epidemiology, Fasting, Fatty Liver/complications/epidemiology, Female, Humans, Male, Middle Aged, Non-alcoholic Fatty Liver Disease, Obesity/*complications/epidemiology, Republic of Korea/epidemiology
¸µÅ©

ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
Having either obesity or not, subjects with NAFLD have higher glucose indices, liver enzyme levels, and fibrosis scores than non-obese subjects without NAFLD.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå